📰 Adagene News
Adagene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adagene. Real-time updates on events, politics, business and more.
May 18, 2024
Adagene Inc. (NASDAQ:ADAG – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase of 6.3% from the April 15th total of 14,200 shares. Based on an average daily volume of 25,400 shares, the […]
January 5, 2024
Adagene announced a poster presentation at the American Society of Clinical Oncology (ASCO) 2024 Gastrointestinal (GI) Cancers Symposium, taking place January 18-20 in San Francisco.
October 13, 2023
Adagene announced its poster presentation at the SITC 38th Annual Meeting taking place November 1-5, 2023 in San Diego
August 14, 2023
Adagene Inc. (NASDAQ:ADAG – Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 19,700 shares, a growth of 8.2% from the July 15th total of 18,200 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average […]
April 17, 2023
Adagene Inc. (NASDAQ:ADAG – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 14,600 shares, an increase of 44.6% from the March 15th total of 10,100 shares. Approximately 0.0% of the shares of the stock are sold short. […]
April 2, 2023
HC Wainwright reissued their buy rating on shares of Adagene (NASDAQ:ADAG – Get Rating) in a research report released on Wednesday morning, Benzinga reports. The firm currently has a $5.00 target price on the stock. HC Wainwright also issued estimates for Adagene’s FY2023 earnings at ($1.49) EPS, FY2024 earnings at ($1.36) EPS, FY2026 earnings at […]
April 2, 2023
Adagene Inc. (NASDAQ:ADAG – Get Rating) – Analysts at HC Wainwright upped their FY2023 earnings per share (EPS) estimates for Adagene in a research note issued to investors on Wednesday, March 29th. HC Wainwright analyst A. He now expects that the company will post earnings of ($1.49) per share for the year, up from their […]
April 2, 2023
HC Wainwright restated their buy rating on shares of Adagene (NASDAQ:ADAG – Get Rating) in a report released on Wednesday, Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. HC Wainwright also issued estimates for Adagene’s FY2023 earnings at ($1.49) EPS, FY2024 earnings at ($1.36) EPS, FY2026 earnings at ($0.87) EPS […]
March 31, 2023
Adagene Inc. (NASDAQ:ADAG – Get Rating) – Equities researchers at HC Wainwright issued their FY2027 earnings estimates for shares of Adagene in a research report issued to clients and investors on Wednesday, March 29th. HC Wainwright analyst A. He forecasts that the company will post earnings per share of ($0.27) for the year. HC Wainwright […]
March 24, 2023
HC Wainwright reissued their buy rating on shares of Adagene (NASDAQ:ADAG – Get Rating) in a research note released on Tuesday morning, Benzinga reports. The brokerage currently has a $5.00 target price on the stock. Separately, Morgan Stanley lowered their price objective on Adagene from $7.00 to $5.00 and set an overweight rating on the […]